Am J Transplant, Volume 18, Suppl 3 Archives - Page 203 of 211 - ATC Abstracts

2018 American Transplant Congress
Elevated Levels of CD19⁺ B Cells before or after Rituximab Administration is a Risk Factor for the Early Rejection of a Living Kidney Transplant
M. Kono,¹ H. Shirakawa,² S. Wakai.¹
¹Nephrology, Ohkubo Hospital, Tokyo, Japan; ²Urology, Ohkubo Hospital, Tokyo, Japan.
[Introduction]Rituximab (RTX) is used for desensitization in highly sensitized patients, such as those undergoing ABO-incompatible (ABOi) kidney transplantation. Although RTX is generally effective, some patients…
2018 American Transplant Congress
Clinical Significance of BK Virus-Specific ELISPOT Assay in Kidney Transplant Recipients
J. Chang,^1,2 H. Bae,³ K. Park,³ H. Lee,³ B. Choi,^1,2 C. Park,^1,2 C. Yang,^1,2 Y. Kim,^1,2 E-.J. Oh,^1,4 B. Chung.^1,2
¹Transplant Research Center, Seoul St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; ²Division of Nephrology, Department of Internal Medicine, Seoul St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; ³Department of Biomedical Science, Graduate School, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; ⁴Department of Laboratory Medicine, Seoul St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
This study aimed to investigate whether BK virus (BKV)-specific T-cell immunity measured by an interferon-γ enzyme-linked immunospot (ELISPOT) assay can predict the outcome of BKV…
2018 American Transplant Congress
Do We Need to Worry about EBV DNAemia in the Late Post-Transplant Period?
M. Morton,¹ K. Daga,² P. Klapper,² M. Picton,¹ P. Vallely.²
¹Department of Renal Medicine, Manchester Royal Infirmary, Manchester, United Kingdom; ²University of Manchester, Manchester, United Kingdom.
Background: Despite detectable Epstein-Barr virus (EBV) in blood, kidney transplant patients (KTR) may have no apparent clinical consequence. This study aims to explore the clinical…
2018 American Transplant Congress
5-Year Serum Alkaline Phosphatase Levels after Kidney Transplantation is Associated with Long-Term Graft Survival and Mortality in Kidney Recipient
H. Choi,¹ D. Kim,^2,3 K. Huh,^2,3 Y. Kim,^2,3 B. Kim.^1,3
¹Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; ²Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; ³The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Background: Previous studies have attempted to identify risk factors of renal graft injury that can be used to improve long-term graft survival. Recently, higher serum…
2018 American Transplant Congress
Changes in Vitamin D Levels after Kidney Transplantation
E. Lum, K. Phonphok, N. Datta, S. Bunnapradist.
Nephrology, UCLA David Geffen School of Medicine, Los Angeles, CA.
IntroductionLow levels of serum vitamin D are common and associated adverse renal outcomes. The frequency of hypovitaminosis D following kidney transplantation (KT) is not well…
2018 American Transplant Congress
SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes
M. Guthoff,¹ M. Mahling,¹ S. Nadalin,² N. Heyne.¹
¹Dept. of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; ²Dept. of General, Visceral and Transplant Surgery, University of Tübingen, Tübingen, Germany.
Purpose: Sodium-glucose cotransporter 2 (SGLT2) inhibition has been shown to reduce cardiovascular mortality and preserve kidney function in patients with type 2 diabetes. Kidney transplant…
2018 American Transplant Congress
The Utility and Futility of Extra-Corporeal Membrane Oxygenation in Liver Transplant Recipients
B. Nguyen, K. Dhanireddy, Y. Genyk, N. Kaur.
University of Southern California, Los Angeles, CA.
Extra-corporeal membrane oxygenation (ECMO) is a therapeutic modality used to treat refractory hypoxemia, and help support cardiogenic shock. These conditions are seen in liver transplant…
2018 American Transplant Congress
Measuring and Monitoring Equity in Access to Deceased Donor Liver Transplants
D. Stewart, A. Robinson, A. Harper, D. Klassen.
UNOS, Richmond.
Background: In 2016, the Organ Procurement and Transplantation Network (OPTN) developed a methodology to measure equity in deceased donor kidney allocation and has adapted it…
2018 American Transplant Congress
Predicting Liver Allograft Discard: The Discard Risk Index
A. Rana, M. Kueht, N. Galvan, R. Cotton, T. Miloh, C. O'Mahony, J. Goss.
Abdominal Transplantation, Baylor College of Medicine, Houston, TX.
Background: An index that predicts liver allograft discard can effectively grade allografts and can be used to preferentially allocate marginal allografts to aggressive centers. Aim:…
2018 American Transplant Congress
MELD Based Allocation Deteriorates Patient Survival without Improving Waiting List Mortality in a Low Donor Area
P. Ritschl, L. Wiering, F. Aigner, M. Biebl, D. Eurich, M. Schmelzle, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
Department of Surgery, Campus Charité Mitte / Campus Virchow-Klinikum CCM/CVK, Charité - Universitätsmedizin Berlin, Berlin, Germany.
The MELD-based allocation system has been implemented in Germany in 2006 in order to decrease waiting list mortality in patients with end stage liver disease.…